Results

Total Results: 925 records

Showing results for "diabetic".
Users also searched for: diabetes

61. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/X--G2-2BHMVFkywKRV6tzC
    August 24, 2021 - Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement Clinical Review & Education (Reprinted) JAMA | US Preventive Services Task Force | RECOMMENDATION STATEMENT Screening for Prediabetes and Type 2 Diabetes US Preventive Services Task Force Recommendation Sta…

62. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/g2bEcQW6ae_NTFZ9KUxT_t
    August 24, 2021 - Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement Clinical Review & Education (Reprinted) JAMA | US Preventive Services Task Force | RECOMMENDATION STATEMENT Screening for Prediabetes and Type 2 Diabetes US Preventive Services Task Force Recommendation Sta…

63. Evidence Summary: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-for-prediabetes-and-type-2-diabetes
    August 24, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Prediabetes and Type 2 Diabetes: Screening August 24, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be const…

64. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients … Pharmacotherapy of Diabetes: New Developments: Improving Life and Prognosis for Diabetic Patients . … Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure … Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients … Aspirin possibly reduces cerebrovascular events in type 2 diabetic patient with higher C-reactive protein

65. Screening for Prediabetes and Type 2 Diabetes in Children: Clinical Summary (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/UHEkFHhddYa3YXX6Mk-gac
    September 01, 2022 - Screening for Prediabetes and Type 2 Diabetes in Children: Clinical Summary The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Clinician Summary o…

66. Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/gestational-diabetes-screening
    August 10, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Gestational Diabetes: Screening August 10, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an …

67. Draft Recommendation: Gestational Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/gestational-diabetes-mellitus-screening1
    February 16, 2021 - in progress Draft Recommendation Statement Gestational Diabetes: Screening February 16, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Heal…

68. Draft Recommendation: Gestational Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/gestational-diabetes-screening
    February 16, 2021 - in progress Draft Recommendation Statement Gestational Diabetes: Screening February 16, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Heal…

69. Screening for Abnormal Blood Glucose & Type 2 Diabetes Mellitus (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z7sxYGwLJxcUMpH9htc92j
    October 01, 2015 - Screening for Abnormal Blood Glucose & Type 2 Diabetes Mellitus Understanding Task Force Recommendations October 2015 Task Force FINAL Recommendation | 1 Screening for Abnormal Blood Glucose & Type 2 Diabetes Mellitus The U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statemen…

70. Final Research Plan: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prediabetes-and-type-2-diabetes-mellitus-screening
    November 15, 2018 - in progress Final Research Plan Prediabetes and Type 2 Diabetes: Screening November 15, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health a…

71. Final Research Plan: Screening for Prediabetes and Type 2 Diabetes | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prediabetes-and-type-2-diabetes-screening
    November 15, 2018 - in progress Final Research Plan Screening for Prediabetes and Type 2 Diabetes November 15, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Healt…

72. Final Research Plan: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-for-prediabetes-and-type-2-diabetes
    November 15, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Prediabetes and Type 2 Diabetes: Screening November 15, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be co…

73. Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MtCxSYE8eYd2EzUGV8cMzH
    June 02, 2008 - Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement Figure. Screening for type 2 diabetes mellitus in adults: clinical summary of a U.S. Preventive Services Task Force (USPSTF) recommendation statement. Screening for Type 2 Diabetes Mellitus in Adults Clinic…

74. Screening for Gestational Diabetes: Clinician Summary for USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/qPSAJPnBVmzFneXUDMRJfs
    August 01, 2021 - Screening for Gestational Diabetes: Clinician Summary for USPSTF Recommendation 1 www.uspreventiveservicestaskforce.org Clinician Summary of USPSTF Recommendation Screening for Gestational Diabetes August 2021 The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clini…

75. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
    July 13, 2021 - Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (Reprinted) Clinical Review & Education JAMA | US Preventive Services Task Force | EVIDENCE REPORT Screening for Prediabetes and Type 2 Diabetes Updated Evidence Report and Syst…

76. Tjdzc7Rzm3Wzcdhfc4Sjhq (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TjDzC7rzm3WzCDHFC4sJhQ
    June 01, 2015 - Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic … Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, … Control: Health/diabetic education once a month (n=86) Patients with IGT and BMI >19 A vs.

77. Final Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-adults-interventions
    March 31, 2016 - pharmacologic interventions Outcomes KQ 1: Health outcomes: Mortality Morbidity (e.g., diabetic

78. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening
    November 15, 2008 - archived Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes? Diabetes Mellitus (Type 2) in Adults: Screening November 15, 2008 Recommendations made by the USPSTF are independent of the U.S. government. They should not…

79. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening-2008
    November 15, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes? Diabetes Mellitus (Type 2) in A…

80. Screening: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/-screening-evidence-summary/gestational-diabetes-mellitus-screening
    May 15, 2013 - Screening: Evidence Summary Gestational Diabetes Mellitus, Screening May 15, 2013 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Servi…